CHA₂DS₂-VASc Score: A Predictor of Thromboembolic Events and Mortality in Patients With an Implantable Monitoring Device Without Atrial Fibrillation.

ABSTRACT:

Objective

To determine if the CHA₂DS₂-VASc score (congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, stroke or transient ischemic attack, vascular disease, age 65-74 years, sex category) predicts thromboembolism and death in patients without atrial fibrillation in a population with implantable cardiac monitoring devices.

Patients and methods

A retrospective review utilizing the Rochester Epidemiology Project research infrastructure was conducted to evaluate the CHA₂DS₂-VASc tool as a predictor of mortality and ischemic stroke, transient ischemic attack, or systemic embolism in patients without atrial fibrillation. An implantable device was required in the inclusion criteria to discern the absence of atrial fi

SUBMITTER: Parsons C 

PROVIDER: S-EPMC5641434 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature